AbbVie Agrees to $24 Million Settlement with California Department of Insurance and Whistleblower Over Humira Marketing Fraud

Lawsuit alleged AbbVie pharmaceutical company committed fraud in promotion of blockbuster prescription drug Humira The California Department of Insurance has announced a settlement agreement with AbbVie Inc. to resolve a lawsuit alleging the pharmaceutical giant violated the California Insurance Frauds Prevention Act (Act) by providing kickbacks to healthcare providers throughout California relating to the sale of its

2020-09-21T15:37:09+00:00September 21st, 2020|Whistleblower Law|

AbbVie Medical Fraud Lawsuit Highlights Growing Nationwide Concern With Big Pharma Paying Doctors to Get New Customers

As reported by USA Today, there is a growing concern across the U.S. over the apparent surge in dangerous and highly expensive medications being pushed on the public by drug manufactures whose main concern is not turning a new corner in patient health but rather turning over millions in profits.

2019-08-13T14:54:56+00:00August 13th, 2019|Whistleblower Law|

Plaintiffs Get AbbVie Medical Fraud Case Remanded to State Court

On September 18, 2018, Lieff Cabraser and California Insurance Commissioner Dave Jones sued AbbVie, Inc. for violations of the Insurance Frauds Prevention Act (“IFPA”) by providing kickbacks to healthcare providers throughout California relating to sale of the immunosuppressive drug Humira. Defendant AbbVie removed the case to federal court, arguing that the State of California should

2019-08-12T11:48:51+00:00August 12th, 2019|Whistleblower Law|

California Department of Insurance Intervenes in Lieff Cabraser’s Lawsuit Against AbbVie Alleging Kickbacks and Improper Marketing of Top-Selling Drug Humira

Joint Complaint Filed Under the California Insurance Frauds Prevention Act On September 18, 2018, Lieff Cabraser and California Insurance Commissioner Dave Jones sued AbbVie, Inc. for violations of the Insurance Frauds Prevention Act (“IFPA”) by providing kickbacks to healthcare providers throughout California relating to sale of the immunosuppressive drug Humira. Humira, used to treat arthritis,

2018-09-18T13:08:35+00:00September 18th, 2018|Consumer Fraud, Whistleblower Law|

Title